morphiceptin, n-me-phe(3)- has been researched along with bromodeoxyuridine in 1 studies
| Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
|---|---|---|---|---|---|
| 95 | 1 | 1 | 13,164 | 71 | 1,816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hauser, KF; Knapp, PE; Maderspach, K | 1 |
1 other study(ies) available for morphiceptin, n-me-phe(3)- and bromodeoxyuridine
| Article | Year |
|---|---|
Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.
Topics: Animals; Animals, Newborn; Antimetabolites; Bromodeoxyuridine; Cell Size; Cells, Cultured; Endorphins; Immunohistochemistry; Mice; Mice, Jimpy; Mitogens; Oligodendroglia; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1998 |